题名 | Expression of D2RmRNA isoforms and ERmRNA isoforms in prolactinomas: correlation with the response to bromocriptine and with tumor biological behavior |
作者 | |
发表日期 | 2010-08 |
发表期刊 | JOURNAL OF NEURO-ONCOLOGY 影响因子和分区 |
语种 | 英语 |
原始文献类型 | Article |
关键词 | Prolactinoma Dopamine 2 receptor isoforms Estrogen receptor isoforms Dopamine agonist Invasiveness |
其他关键词 | RECEPTOR MESSENGER-RNA ; DOPAMINE D2 RECEPTOR ; PITUITARY-ADENOMAS ; CAVERNOUS SINUS ; RESISTANT ; ESTROGEN ; ESTRADIOL ; RELEASE |
摘要 | Invasive prolactinomas are more likely to be resistant to drug therapy but the mechanism of this is still unknown. The objective of this study was to analyze the different expression of ERmRNA and D2RmRNA isoforms in prolactinomas responsive and resistant to dopamine agonist (DA), and to discuss the correlation of such gene expression with tumor biological behavior. A prospective study of 20 consecutive patients who harbored prolactinomas was designed. Patients were classified as responsive (14 cases) or resistant (six cases) according to their clinical and biochemical response to bromocriptine. Tumor tissue samples were examined by means of QRT-PCR analysis. Median D2SmRNA expression in responsive patients was about 2.5-fold that in resistant ones (13.5 +/- A 10.4 and 5.4 +/- A 2.4, respectively, P = 0.09). No significant difference was found between D2LmRNA expression levels (P = 0.77). However, there was a significant difference between D2S/D2LmRNA ratios for responsive and resistant tumors (P = 0.012). A significant difference was not found between these two groups in levels of ER alpha mRNA and ER beta mRNA expression (P = 0.20 and 0.06, respectively). D2SmRNA expression was significantly different for invasive and noninvasive tumors (6.2 +/- A 3.6 vs. 17.0 +/- A 11.2, respectively, P = 0.02). The D2S/D2L ratio is related to the responsiveness of prolactinomas to DA medication, in which D2SmRNA plays an important role. Lower expression of D2SmRNA in invasive tumor patients suggests that invasive prolactinomas may be more likely to be resistant to DA medication. |
资助项目 | National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30800347]; Science and Technology Department of Zhejiang Province [2007C33028]; Health Bureau of Zhejiang Province [2007A138]; Wenzhou Science and Technology Bureau [H20070040] |
出版者 | SPRINGER |
出版地 | NEW YORK |
ISSN | 0167-594X |
EISSN | 1573-7373 |
卷号 | 99期号:1页码:25-32 |
DOI | 10.1007/s11060-009-0107-y |
页数 | 8 |
WOS类目 | Oncology ; Clinical Neurology |
WOS研究方向 | Oncology ; Neurosciences & Neurology |
WOS记录号 | WOS:000279459400003 |
收录类别 | SCIE ; PUBMED ; SCOPUS |
URL | 查看原文 |
PubMed ID | 20063113 |
SCOPUSEID | 2-s2.0-77954385678 |
通讯作者地址 | [Zhuge Q. C.]Department of Neurosurgery,First Affiliated Hospital,Wenzhou Medical College,China |
Scopus学科分类 | Oncology;Neurology;Neurology (clinical);Cancer Research |
引用统计 | |
文献类型 | 期刊论文 |
条目标识符 | https://kms.wmu.edu.cn/handle/3ETUA0LF/16982 |
专题 | 第一临床医学院(信息与工程学院)、附属第一医院_外科学_神经外科 附属第一医院 |
作者单位 | 1.Department of Neurosurgery,First Affiliated Hospital,Wenzhou Medical College,China; 2.Biomedical Engineering Center,Biomechanics and Medical Information Institute,Beijing University of Technology,China |
第一作者单位 | 附属第一医院 |
通讯作者单位 | 附属第一医院 |
第一作者的第一单位 | 附属第一医院 |
推荐引用方式 GB/T 7714 | Wu, Zhe Bao,Zheng, Wei Ming,Su, Zhi Peng,et al. Expression of D2RmRNA isoforms and ERmRNA isoforms in prolactinomas: correlation with the response to bromocriptine and with tumor biological behavior[J]. JOURNAL OF NEURO-ONCOLOGY,2010,99(1):25-32. |
APA | Wu, Zhe Bao., Zheng, Wei Ming., Su, Zhi Peng., Chen, Yong., Wu, Jin Sen., ... & Zhuge, Qi Chuan. (2010). Expression of D2RmRNA isoforms and ERmRNA isoforms in prolactinomas: correlation with the response to bromocriptine and with tumor biological behavior. JOURNAL OF NEURO-ONCOLOGY, 99(1), 25-32. |
MLA | Wu, Zhe Bao,et al."Expression of D2RmRNA isoforms and ERmRNA isoforms in prolactinomas: correlation with the response to bromocriptine and with tumor biological behavior".JOURNAL OF NEURO-ONCOLOGY 99.1(2010):25-32. |
条目包含的文件 | 条目无相关文件。 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论